International Clinical Trial: UV-A Protection Factor of Foxtale FDSS1

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104916) titled 'UV-A Protection Factor of Foxtale FDSS1' on Feb. 26.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Foxtale Consumer Pvt Ltd.

Intervention: Intervention1: Test product: FDSS1: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour Control Intervention1: Reference Sunscreen: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour

Recruitment Status: Not Recruiting

Phase: Post Market...